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Abstract We present the first X-ray study of a member of the 
arrestin family, the bovine retinal arrestin. Arrestin is essential 
for the fine regulation and termination of the light-induced 
enzyme cascade in vertebrate rod outer segments. It plays an 
important role in quenching phototransduction by its ability to 
preferentially bind to phosphorylated light-activated rhodopsin. 
The crystals diffract between 3 A and 3.5 A (space group P2i2i2, 
cell dimensions a = 169.17 Á, b = 185.53 À, c = 90.93 À, T = 100 
K). The asymmetric unit contains four molecules with a solvent 
content of 68.5% by volume. 
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1. Introduction 
In vertebrate photoreceptors, a light signal initiates an en-
zyme cascade leading to a decrease in concentration of the 
internal transmitter cGMP and subsequently to the closure 
of cation channels in the plasma membrane, which are kept 
open by cGMP in the dark. 
Besides the visual pigment rhodopsin (R), four cytoplasmic 
proteins play a key role in the activation and inactivation of 
the light-induced enzyme cascade. These proteins are the gua-
nine nucleotide binding protein (G-protein) called transducin 
(TaßT), the rhodopsin kinase, the regulatory protein arrestin 
(also termed S-antigen or 48 kDa protein), and the phospho-
diesterase (PDE). 
In its light-activated conformation (R*) the receptor protein 
rhodopsin interacts with transducin (TaßY) inducing thereby 
the exchange of GDP bound to T a for a GTP molecule [1]. 
The Ta-GTP subunit dissociates from TßY and from R* [2] 
and activates the PDE [3,4] by removing the inhibitory sub-
unit PDEy [5-7]. The resulting decrease in cGMP concentra-
tion causes the closure of cation channels in the plasma mem-
brane [8-10]. 
Since binding and dissociation of transducin takes only 
about 1 ms [11], a single R* can readily interact with hun-
dreds of transducin molecules in less than a second, thereby 
leading to the activation of hundreds of PDE molecules. PDE 
is an enzyme with a very high turnover number (up to 2000 
cGMP/PDE s_1). Therefore, a single photon of light, if lead-
ing to hundreds of activated PDE molecules, would be able to 
hydrolyze the entire cGMP pool of a photoreceptor cell with-
in a second. To limit the amplitude of light response, only a 
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few PDE molecules should be allowed to become activated in 
response to dim light, i.e. R* has to be rapidly blocked well 
before it can interact with too many transducin molecules. 
Inactivation of R* can be performed in two steps : phospho-
rylation of R* at multiple sites by the rhodopsin kinase re-
duces its ability to activate transducin [12-15] and subsequent 
binding of arrestin completely blocks it from further interac-
tion with transducin [16]. Thus, arrestin is essentially involved 
in terminating the light response. 
Soon after the clarification of the function of arrestin in 
vision, a protein was discovered and called ß-arrestin, which 
shields the agonist occupied, phosphorylated ß-adrenergic re-
ceptor from binding to G-proteins in a similar way [17]. 
Meanwhile, arrestin-like proteins have been discovered in sev-
eral other species and tissues: in various bovine tissues [18], in 
turkey erythrocytes [19], in the photoreceptor of Drosophila 
[20,21], in human thyroid [22], in yeast cells [23], and many 
others. Arrestin-like proteins are expected to be common to 
G-protein coupled receptors and essentially required for the 
receptor down regulation and adaptation. 
Arrestin is one of the most abundant soluble proteins of the 
vertebrate photoreceptor cell [24]. The cloning of a bovine 
retinal cDNA revealed that arrestin has 404 amino acids 
(45.3 kDa). 
Here we report the first crystallization and preliminary X-
ray analysis of a member of the arrestin family, the bovine 
retinal arrestin. Elucidation of this protein structure by X-ray 
crystallography will give insight into the three-dimensional 
architecture and provide a basis to clarify the interaction be-
tween phosphorylated, activated rhodopsin and arrestin. 
2. Materials and methods 
Rod outer segments (ROS) were purified from fresh bovine eyes as 
described by Wilden and Kühn [12]. They were kept in the dark and 
stored in aliquots at —80°C. 
Retina extract was prepared as follows: 70 retinae that had been 
frozen in liquid N2 were thawed in 70 ml of sodium phosphate buffer 
(pH 7.2). They were shaken vigorously by hand for 90 s and then 
gently stirred for 30 min on ice. After centrifugation for 30 min at 
20 000 rpm in a Beckman JA-20 rotor, the supernatant was collected 
and stored at —80°C in aliquots of 20 ml until use. 
Arrestin was purified using its light-dependent binding to phos-
phorylated rhodopsin as described earlier [25] with some modifica-
tions. Briefly, a ROS pellet containing ca. 30 mg of rhodopsin was 
homogenized in 30 ml of 70 mM sodium phosphate (pH 7.2), 2 mM 
MgCl2/0.1 mM EDTA/3 mM ATP/1 mM GTP and illuminated at 
30°C with white light. After 20 min 40 ml retina extract was added, 
and the mixture was illuminated for another 10 min at 30°C. The 
suspension was centrifuged for 30 min at 20 000 rpm. The supernatant 
was discarded and the pellet washed three times by resuspending it 
each time with 60 ml of 10 mM HEPES (pH 7.2)/0.1 mM EDTA and 
centrifuging for 40 min at 20 000 rpm. In the first wash, 0.1 mM GTP 
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was added. The pellet was then washed gently with 8 ml of 10 mM 
HEPES (pH 7.2)/400 mM KC1 in order to remove unspecific bound 
proteins. Finally the pellet was suspended in 10 ml of 10 mM HEPES 
(pH 7.2)/800 mM KC1 and incubated at 20°C in the dark for ca. 16 h. 
The suspension was then centrifuged at 20000 rpm for 30 min. The 
supernatant containing the purified arrestin was centrifuged again to 
remove residual membrane particles and stored at — 80°C in aliquots. 
For crystallization purposes, arrestin was concentrated to approx. 
36 mg/ml using a Centricon-30 concentrator. 10 ul of concentrated 
arrestin was mixed with 7-10 |il of 18 mM PIPES pH 7.2/0.5 M KC1/ 
30% ethylene glycol/8% polyethylene glycol 6000/18% polyethylene 
glycol 200/6% polyethylene glycol 1000. Crystals were grown in hang-
ing drops by vapor diffusion against 40 mM PIPES pH 7.2/0.6 M 
KCl/22% ethylene glycol/5.7% polyethylene glycol 6000/13% polyeth-
ylene glycol 200/4% polyethylene glycol 1000 at room temperature. 
Protein from solubilized crystals as well as protein used for crystal-
lization was verified as full-length bovine arrestin by SDS-PAGE (so-
dium dodecyl sulfate-polyacrylamide gel electrophoresis) [26] and 
Western blot (data not shown). 
Crystals with dimensions of approximately 0.3X0.2X0.15 mm grew 
within 2-3 weeks. Their shape was pinacoid with commonly prismatic 
surfaces of {100}, {010} and {001} (Fig. 1). 
Native and first derivative datasets were collected using synchrotron 
radiation sources at the Science and Energy Research Council (SERC, 
UK) Daresbury Laboratory, European Molecular Biology Labora-
tory (EMBL) outstation at the Deutsches Electronen Synchrotron 
(DESY, Germany) Hamburg and at LURE (Orsay, France). 
3. Results and discussion 
As outlined in Section 1, arrestin is an important modulator 
for G-protein signal transduction in different cellular proc-
esses. So far no crystal structure of a member of the arrestin 
family has been published or its crystallization reported. The 
reason for this may lie in the unusual behavior of arrestin we 
observed during our crystallization procedures. A rapid initial 
screening of crystallization conditions was conducted using a 
sparse matrix without any success. After a long search only a 
mixture of different molecular weight species of polyethylene 
glycols, as described in Section 2, was successful. 
Arrestin crystallizes in the orthorhombic space group 
P2i2i2, two screw axes and one twofold axis were verified 
by native Patterson synthesis and its possible Harker sections. 
The unit cell dimensions are a =169.17 A, b= 185.53 A, 
c = 90.95 À (T= 100 K). A Vm value of 3.94 Á
3 D a - 1 is con-
sistent with the presence of four molecules in the asymmetric 
unit. This value is in the upper range of values tabulated by 
Matthews [27]. The solvent content is estimated to be 68.5%. 
Due to the strong X-ray radiation damage of the crystals all 
datasets were collected under cryo-conditions. The crystals 
were soaked prior to flash-freezing to 100 K (nitrogen gas 
stream) in reservoir solution containing 0.1% glutaraldehyde 
and subsequently in 2.5 mM imidazole. All X-ray diffraction 
data were collected on MAR Research image-plate area de-
tector. The measurements were evaluated, scaled and merged 
by the programs DENZO [28], SCALA and AGROVATA 
[29]. The actual resolution was 3.0 A with a data completeness 
of 90.3% and a Rsym = 0.077. 
An examination of the self-rotation function (program PO-
LARRFN) [29] reveals one major (85% of origin height) and 
one minor peak (27% height) in the K=180° section, using 
data from 20.0 to 6.0 A and 20 A radius of integration (ro-
tation function not shown). The major twofold non-crystallo-
graphic symmetry (ncs) operation is nearly parallel to the c-
axis, the minor ncs operation lies perpendicular to the first 
operation axis. The two different sets of twofold ncs symme-
Fig. 1. Crystal of arrestin. The crystal size corresponds to approxi-
mately 0.18X0.17X0.15 mm. 
tries reflect that the molecules are only identical by pairs. The 
differences between the pairs may result from crystal packing 
effects. 
A further search for suitable heavy-atom derivatives to 
solve the structure by multiple isomorphous replacement 
methods is still in progress, but the first SIRAS (single iso-
morphous replacement, anomalous scattering) electron-den-
sity map is predominantly interpretable. A first model build-
ing at 3.5 A is under way and not yet finished, but we can 
clearly see that the arrestin structure is dominated by two 
domains of antiparallel ß-sheets connected via a hinge region 
and one short ot-helix on the backside of the N-terminal do-
main. The overall amounts in the elements of the secondary 
structure are in accordance with spectroscopic (CD and 
FTIR) results of Shinohara et al. [30] and Garcia-Quintana 
et al. [31]. There are no extended coil regions. Therefore we 
cannot agree with the interpretation of Gurevich and Benovic 
[32] that the binding domain of arrestin to the activated and 
phosphorylated rhodopsin has no distinct features in the sec-
ondary structure. The postulated region must be located in 
one of the ß-strands. 
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